Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 6/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.35 |
| ▸ | PYGL | P06737 | 3/20 | 0.34 |
| ▸ | PYGM | P11217 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9460420 | 0.78 | PYGB (0.41) | PYGB | |
| SCHEMBL28575710 | 0.76 | PYGB (0.48) | PYGBPYGLPYGM | |
| SCHEMBL5062195 | 0.76 | PYGB (0.48) | PYGBPYGLPYGM | |
| SCHEMBL23349270 | 0.75 | PYGB (0.39) | PYGBLGALS3PYGLPYGML3MBTL1 | |
| SCHEMBL2844313 | 0.75 | PYGB (0.57) | PYGBLGALS3PYGLPYGM | |
| SCHEMBL170235 | 0.74 | PYGB (0.40) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL14977692 | 0.70 | PYGB (0.37) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL10850848 | 0.68 | PYGB (0.40) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL9095367 | 0.68 | PYGB (0.40) | PYGBPYGLPYGM | |
| SCHEMBL27453207 | 0.67 | PYGB (0.44) | PYGBPYGLPYGMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2360471-B1 | METHOD FOR PRE-TREATING SAMPLE CONTAINING GLYCATED HEMOGLOBIN | SEKISUI MEDICAL CO LTD (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-9341633-B2 | Method for pre-treating sample containing glycated hemoglobin | SEKISUI MEDICAL CO., LTD. (JP) | 2016-05-17 | — | — | US | disclosed |
| US-20110318765-A1 | METHOD FOR PRE-TREATING SAMPLE CONTAINING GLYCATED HEMOGLOBIN | SEKISUI MEDICAL CO., LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2360471-A1 | METHOD FOR PRE-TREATING SAMPLE CONTAINING GLYCOSYLATED HEMOGLOBIN | Sekisui Medical Co., Ltd. (JP) | 2011-08-24 | — | — | EP | disclosed |